Literature DB >> 24648565

Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

Roberto Gasparini1, Maurizio Comanducci2, Daniela Amicizia3, Filippo Ansaldi3, Paola Canepa3, Andrea Orsi3, Giancarlo Icardi3, Emanuela Rizzitelli3, Gabriella De Angelis2, Stefania Bambini2, Monica Moschioni2, Sara Comandi2, Isabella Simmini2, Giueseppe Boccadifuoco2, Brunella Brunelli2, Marzia Monica Giuliani2, Mariagrazia Pizza2, Donatella Panatto1.   

Abstract

Neisseria meningitidis is an obligate human commensal that commonly colonizes the oropharyngeal mucosa. Carriage is age dependent and very common in young adults. The relationships between carriage and invasive disease are not completely understood. In this work, we performed a longitudinal carrier study in adolescents and young adults (173 subjects). Overall, 32 subjects (18.5%) had results that were positive for meningococcal carriage in at least one visit (average monthly carriage rate, 12.1%). Only five subjects tested positive at all four visits. All meningococcal isolates were characterized by molecular and serological techniques. Multilocus sequence typing, PorA typing, and sequencing of the 4CMenB vaccine antigens were used to assess strain diversity. The majority of positive subjects were colonized by capsule null (34.4%) and capsular group B strains (28.1%), accounting for 23.5% and 29.4% of the total number of isolates, respectively. The fHbp and nhba genes were present in all isolates, while the nadA gene was present in 5% of the isolates. The genetic variability of the 4CMenB vaccine antigens in this collection was relatively high compared with that of other disease-causing strain panels. Indications about the persistence of the carriage state were limited to the time span of the study. All strains isolated from the same subject were identical or cumulated minor changes over time. The expression levels and antigenicities of the 4CMenB vaccine antigens in each strain were analyzed by the meningococcal antigen typing system (MATS), which revealed that expression can change over time in the same individual. Future analysis of antigen variability and expression in carrier strains after the introduction of the MenB vaccine will allow for a definition of its impact on nasopharyngeal/oropharyngeal carriage.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24648565      PMCID: PMC4042792          DOI: 10.1128/JCM.03584-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  59 in total

1.  Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.

Authors:  Brian D Plikaytis; Maria Stella; Giuseppe Boccadifuoco; Lisa M DeTora; Mauro Agnusdei; Laura Santini; Brunella Brunelli; Luca Orlandi; Isabella Simmini; Marzia Giuliani; Morgan Ledroit; Eva Hong; Muhamed-Kheir Taha; Kim Ellie; Gowrisankar Rajam; George M Carlone; Heike Claus; Ulrich Vogel; Ray Borrow; Jamie Findlow; Stefanie Gilchrist; Paola Stefanelli; Cecilia Fazio; Anna Carannante; Jan Oksnes; Elisabeth Fritzsønn; Anne-Marie Klem; Dominique A Caugant; Raquel Abad; Julio A Vázquez; Rino Rappuoli; Mariagrazia Pizza; John J Donnelly; Duccio Medini
Journal:  Clin Vaccine Immunol       Date:  2012-08-08

Review 2.  Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease.

Authors:  Peter M Dull; E David McIntosh
Journal:  Vaccine       Date:  2012-05-30       Impact factor: 3.641

3.  Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

Authors:  Ulrich Vogel; Muhamed-Kheir Taha; Julio A Vazquez; Jamie Findlow; Heike Claus; Paola Stefanelli; Dominique A Caugant; Paula Kriz; Raquel Abad; Stefania Bambini; Anna Carannante; Ala Eddine Deghmane; Cecilia Fazio; Matthias Frosch; Giacomo Frosi; Stefanie Gilchrist; Marzia M Giuliani; Eva Hong; Morgan Ledroit; Pietro G Lovaglio; Jay Lucidarme; Martin Musilek; Alessandro Muzzi; Jan Oksnes; Fabio Rigat; Luca Orlandi; Maria Stella; Danielle Thompson; Mariagrazia Pizza; Rino Rappuoli; Davide Serruto; Maurizio Comanducci; Giuseppe Boccadifuoco; John J Donnelly; Duccio Medini; Ray Borrow
Journal:  Lancet Infect Dis       Date:  2013-02-13       Impact factor: 25.071

4.  The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans.

Authors:  Daniela Toneatto; Shevqet Ismaili; Ellen Ypma; Kay Vienken; Philipp Oster; Peter Dull
Journal:  Hum Vaccin       Date:  2011-06-01

Review 5.  Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region.

Authors:  Montse Soriano-Gabarró; Joanne Wolter; Cosmina Hogea; Andrew Vyse
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

Review 6.  The changing and dynamic epidemiology of meningococcal disease.

Authors:  Scott A Halperin; Julie A Bettinger; Brian Greenwood; Lee H Harrison; Jane Jelfs; Shamez N Ladhani; Peter McIntyre; Mary E Ramsay; Marco A P Sáfadi
Journal:  Vaccine       Date:  2011-12-15       Impact factor: 3.641

Review 7.  Neisseria meningitidis, pathogenetic mechanisms to overcome the human immune defences.

Authors:  R Gasparini; D Amicizia; P L Lai; D Panatto
Journal:  J Prev Med Hyg       Date:  2012-06

Review 8.  A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?

Authors:  Natalie G Martin; Matthew D Snape
Journal:  Expert Rev Vaccines       Date:  2013-08       Impact factor: 5.217

9.  Conservation of meningococcal antigens in the genus Neisseria.

Authors:  Alessandro Muzzi; Marirosa Mora; Mariagrazia Pizza; Rino Rappuoli; Claudio Donati
Journal:  MBio       Date:  2013-06-11       Impact factor: 7.867

10.  Infant meningococcal vaccination: Advisory Committee on Immunization Practices (ACIP) recommendations and rationale.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-01-25       Impact factor: 17.586

View more
  22 in total

1.  Meningococcal carriage among a university student population - United States, 2015.

Authors:  Lucy Breakwell; Melissa Whaley; Unab I Khan; Utpala Bandy; Nicole Alexander-Scott; Lynn Dupont; Cindy Vanner; How-Yi Chang; Jeni T Vuong; Stacey Martin; Jessica R MacNeil; Xin Wang; Sarah A Meyer
Journal:  Vaccine       Date:  2017-11-26       Impact factor: 3.641

2.  COMPARISON OF METHODS TO IDENTIFY Neisseria meningitidis IN ASYMPTOMATIC CARRIERS.

Authors:  Camila F Rizek; André Machado Luiz; Gracilene Ramos de Assis; Silvia Figueiredo Costa; Anna Sara Levin; Marta Heloisa Lopes
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-09-22       Impact factor: 1.846

3.  Unveiling New Aspects of Meningococcal Carriage and Disease Prevention.

Authors:  Magnus Gottfredsson
Journal:  J Clin Microbiol       Date:  2015-11-18       Impact factor: 5.948

Review 4.  Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes.

Authors:  Alexander Domnich; Roberto Gasparini; Daniela Amicizia; Giuseppe Boccadifuoco; Marzia Monica Giuliani; Donatella Panatto
Journal:  J Immunol Res       Date:  2015-08-17       Impact factor: 4.818

5.  Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines.

Authors:  Eduardo Rojas; Johanna Hoyos; Neil J Oldfield; Philip Lee; Mike Flint; C Hal Jones; Dlawer A A Ala'Aldeen; Kathrin U Jansen; Annaliesa S Anderson
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 6.  How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.

Authors:  R Gasparini; D Panatto; N L Bragazzi; P L Lai; A Bechini; M Levi; P Durando; D Amicizia
Journal:  J Immunol Res       Date:  2015-08-17       Impact factor: 4.818

Review 7.  Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage.

Authors:  G Gabutti; A Stefanati; P Kuhdari
Journal:  J Prev Med Hyg       Date:  2015-08-31

8.  Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis.

Authors:  Roberto Gasparini; Paolo Landa; Daniela Amicizia; Giancarlo Icardi; Walter Ricciardi; Chiara de Waure; Elena Tanfani; Paolo Bonanni; Carlo Lucioni; Angela Testi; Donatella Panatto
Journal:  Hum Vaccin Immunother       Date:  2016-05-10       Impact factor: 3.452

Review 9.  Meningococcal B vaccination strategies and their practical application in Italy.

Authors:  R Gasparini; D Amicizia; P L Lai; D Panatto
Journal:  J Prev Med Hyg       Date:  2015-08-31

Review 10.  [Meningococcus B: control of two outbreaks by vaccination].

Authors:  G Gabutti
Journal:  J Prev Med Hyg       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.